Pancreatic neoplasms.
Patients who present with signs and symptoms suggesting a pancreatic neoplasm typically undergo initial imaging with transabdominal ultrasound or CT. When a pancreatic mass or fullness is identified, it may represent an inflammatory mass, benign process, or malignancy. Endoscopic ultrasound (EUS) is performed commonly to further characterize the lesion, obtain a tissue diagnosis, and for staging. This article reviews the role of EUS for the diagnosis and staging of pancreatic tumors.
Levy
Michael J
MJ
Developmental Endoscopy Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA. levy.michael@mayo.edu
Wiersema
Maurits J
MJ
D000230:Adenocarcinoma / Q000000981:diagnostic imaging / Q000473:pathology; D044963:Biopsy, Fine-Needle / Q000379:methods*; D020420:Cyst Fluid / Q000166:cytology; D018282:Cystadenocarcinoma, Mucinous / Q000000981:diagnostic imaging / Q000473:pathology; D018291:Cystadenoma, Mucinous / Q000000981:diagnostic imaging / Q000473:pathology; D018293:Cystadenoma, Serous / Q000000981:diagnostic imaging / Q000473:pathology; D003560:Cysts / Q000000981:diagnostic imaging / Q000473:pathology; D019160:Endosonography / Q000379:methods*; D006801:Humans; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging / Q000473:pathology; D010182:Pancreatic Diseases / Q000000981:diagnostic imaging / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology*